John W. Higuchi, a director at $LPCN, bought 123,000 shares of the company on 04-06-2026 for an estimated $252,149. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 301.5%. Following this trade, they now own 163,797 shares of this class of $LPCN stock.
$LPCN Insider Trading Activity
$LPCN insiders have traded $LPCN stock on the open market 3 times in the past 6 months. Of those trades, 3 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $LPCN stock by insiders over the last 6 months:
- JOHN W. HIGUCHI purchased 123,000 shares for an estimated $252,149
- MAHESH V. PATEL (Chief Executive Officer) has made 2 purchases buying 50,000 shares for an estimated $101,250 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LPCN Hedge Fund Activity
We have seen 15 institutional investors add shares of $LPCN stock to their portfolio, and 6 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DIADEMA PARTNERS LP added 260,939 shares (+inf%) to their portfolio in Q4 2025, for an estimated $2,095,340
- IKARIAN CAPITAL, LLC added 199,542 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,602,322
- PERSISTENT ASSET PARTNERS LTD added 70,576 shares (+inf%) to their portfolio in Q4 2025, for an estimated $566,725
- MINK BROOK ASSET MANAGEMENT LLC added 66,812 shares (+inf%) to their portfolio in Q1 2026, for an estimated $533,827
- BOOTHBAY FUND MANAGEMENT, LLC added 54,893 shares (+inf%) to their portfolio in Q4 2025, for an estimated $440,790
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 21,852 shares (-46.7%) from their portfolio in Q4 2025, for an estimated $175,471
- AMERIPRISE FINANCIAL INC added 16,104 shares (+inf%) to their portfolio in Q4 2025, for an estimated $129,315
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
